Advertisement
Screener

Eversept Partners, LP Historic Quarter Change: Foreign ADRs, Sold Out

Eversept Partners, LP historic quarter change: Foreign ADRs, Sold out

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Eversept Partners, LP opened 3 positions, added to 2, reduced 3 and sold out of 4.

  • Q1 2026: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 48,241.
  • Q2 2025: Stock AMARIN CORP PLC; Country of operation —; Class SPONS ADR NEW; Shares before 3,399,204.
  • Q1 2025: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 102,661.
  • Q2 2024: Stock MORPHOSYS AG; Country of operation —; Class SPONSORED ADS; Shares before 165,924.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1697013), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2017-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR48,2410-48,241$10,286,911$0-$10,286,9112026-05-15
Q2 2025AMARIN CORP PLC
CUSIP 023111206
SPONS ADR NEW3,399,2040-3,399,204$1,523,183$0-$1,523,1832025-08-14
Q1 2025ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR102,6610-102,661$6,726,349$0-$6,726,3492025-05-15
Q2 2024MORPHOSYS AG
CUSIP 617760202
SPONSORED ADS165,9240-165,924$3,009,861$0-$3,009,8612024-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
Distillate Capital Partners LLCUnited States$1.898B118
SIGMA INVESTMENT COUNSELORS INCUnited States$1.893B194
Cyndeo Wealth Partners, LLCUnited States$1.901B478
TECTONIC ADVISORS LLCUnited States$1.892B332
OSBORNE PARTNERS CAPITAL MANAGEMENT, LLCUnited States$1.891B197
FIRST HORIZON CORPUnited States$1.903B2,094
First Trust Capital Management L.P.United States$1.903B197
HIGHLAND CAPITAL MANAGEMENT, LLCUnited States$1.889B418
Resonant Capital Advisors, LLCUnited States$1.904B495
Oakworth Capital, Inc.United States$1.889B1,253